Agnete Fredriksen, Ph.D.Member of the Board of Directors

Agnete Fredriksen, Ph.D., is a co-founder, president and chief innovation and strategy officer of Nykode Therapeutics AS (formerly Vaccibody AS) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies for cancer and infectious diseases. With prior roles at Affitech AS and Medinnova AS, Agnete’s focus is on developing vaccines from idea to clinical development. She is the author of numerous scientific papers in the field of immunology, immunotherapy and vaccines, and has been awarded several patents in the field of immunotherapy. She holds an MSc and a Ph.D. from the Institute of Immunology, Rikshospitalet Medical Center in Oslo, Norway.